Phase I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HC1 in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

• LISSITCHKOV T

収録刊行物

• J Cancer Res Clin Oncol

  J Cancer Res Clin Oncol 132 99-104, 2006

詳細情報

• CRID: 1573105976081619072
• NII論文ID: 10027831738
• データソース種別:
  • CiNii Articles